Skip to main content

Month: January 2021

Dyne Therapeutics Announces Pricing of $168 Million Public Offering

WALTHAM, Mass., Jan. 20, 2021 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock at a public offering price of $28.00 per share. In addition, Dyne has granted the underwriters a 30-day option to purchase up to 900,000 additional shares of common stock at the public offering price, less the underwriting discount and commissions. All of the shares are being offered by Dyne.The gross proceeds of the offering, before deducting the underwriting discount and commissions and other offering expenses payable by Dyne, are expected to be approximately $168 million, excluding any exercise of the...

Continue reading

Chimerix Announces Pricing of Public Offering of Common Stock

DURHAM, N.C., Jan. 20, 2021 (GLOBE NEWSWIRE) — Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, announced today the pricing of its underwritten public offering of 11,765,000 shares of its common stock at a price to the public of $8.50 per share. All of the shares to be sold in the offering are being sold by Chimerix. The gross proceeds to Chimerix from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be $100.0 million. In addition, Chimerix has granted the underwriters a 30-day option to purchase up to an additional 1,764,750 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close...

Continue reading

Dream Finders Homes, Inc. Announces Pricing of Initial Public Offering

JACKSONVILLE, Fla., Jan. 20, 2021 (GLOBE NEWSWIRE) — Dream Finders Homes, Inc. (NASDAQ: DFH) announced today the pricing of its initial public offering of 9,600,000 shares of Class A common stock at the initial public offering price of $13.00 per share. Shares of DFH’s Class A common stock are expected to begin trading on the NASDAQ Global Select Market under the symbol “DFH” on Thursday, January 21, 2021, and the offering is expected to close on January 25, 2021, subject to customary closing conditions. In addition, DFH has granted the underwriters a 30-day option to purchase up to 1,440,000 additional shares of Class A common stock on the same terms to cover over-allotments.DFH expects to receive gross proceeds from the offering of approximately $124.8 million, before deducting underwriting discounts and estimated offering expenses,...

Continue reading

Ninepoint Partners LP Announces Proposed Fund Merger in 2021

TORONTO, Jan. 20, 2021 (GLOBE NEWSWIRE) — Ninepoint Partners LP (Ninepoint Partners) announced today that it proposes to merge (the Merger) Ninepoint Concentrated Canadian Equity Fund (the Terminating Fund) into Ninepoint Convertible Securities Fund (the Continuing Fund). The Terminating Fund will cease to be available for sale effective immediately. Following the Merger, pre-authorized purchase plans established for purchases of units of the Terminating Fund will be immediately transferred to the equivalent series of units of the Continuing Fund. Through the Merger, holders of units of each series of the Terminating Fund will receive units of the same series of the Continuing Fund determined on a dollar-for-dollar basis.The Independent Review Committee has reviewed the potential conflict of interest matters related to the proposed...

Continue reading

Partenaires Ninepoint LP annonce une fusion de fonds proposée en 2021

TORONTO, 20 janv. 2021 (GLOBE NEWSWIRE) — Partenaires Ninepoint LP (Partenaires Ninepoint) a annoncé aujourd’hui qu’elle propose de fusionner (la fusion) le Fonds Actions canadiennes — concentré Ninepoint (le fonds en dissolution) avec le Fonds de titres convertibles Ninepoint (le fonds maintenu). La vente des titres du fonds en dissolution cessera immédiatement. À la suite de la fusion, les programmes de prélèvements automatiques établis pour l’achat de parts du fonds en dissolution seront transférés aux séries de parts équivalentes du fonds maintenu. Avec la fusion, les porteurs de parts de chaque série du fonds en dissolution recevront des parts de la même série du fonds maintenu, à raison d’un dollar pour chaque dollar détenu.Le comité d’examen indépendant a examiné la question des conflits d’intérêts éventuels liés à la fusion...

Continue reading

Athira Pharma Announces Pricing of Public Offering of Common Stock

BOTHELL, Wash., Jan. 20, 2021 (GLOBE NEWSWIRE) — Athira Pharma, Inc., (Nasdaq: ATHA) (“Athira”), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced the pricing of its underwritten public offering of 4,000,000 shares of its common stock at a public offering price of $22.50 per share. All of the shares of common stock are being offered by Athira. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Athira, are expected to be $90.0 million. The offering is expected to close on January 25, 2021, subject to satisfaction of customary closing conditions. In addition, Athira has granted the underwriters a 30-day option to purchase up to an additional 600,000...

Continue reading

Constellation Software Inc. Announces Annual Interest Rate for Series 1 Debentures

TORONTO, Jan. 20, 2021 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX: CSU, TSX: CSU.DB) (the “Company”) announced today that the interest rate applicable to the unsecured subordinated floating rate debentures, Series 1 of the Company (the “Debentures”) will be reset to 7.2% per annum on March 31, 2021. This new interest rate is equal to the annual average percentage change in the “All-items Consumer Price Index” published by Statistics Canada during the 12 month period ending on December 31, 2020 plus 6.5% and will be reflected in the June 30, 2021 interest payment on the Debentures.The current interest rate of 8.4% will remain in place until March 30, 2021. The interest rate applicable to the Debentures will continue to be reset on an annual basis on March 31 of each year.Further details regarding the Debentures can be found...

Continue reading

Archrock Announces Changes to Board of Directors

HOUSTON, Jan. 20, 2021 (GLOBE NEWSWIRE) — Archrock, Inc. (NYSE:AROC) (“Archrock” or the “Company”) today announced that, on January 20, 2021, Wendell R. Brooks notified the Company of his retirement from the Company’s Board of Directors (the “Board”).  Mr. Brooks has served on the Board since 2015, including as a member of the audit and compensation committees.On January 20, 2021, the Board appointed Leonard W. Mallett to fill the vacant Board seat resulting from Mr. Brooks’s retirement, effective immediately.  Mr. Mallett will serve as a member of the compensation committee of the Board.From December 2015 until his retirement in October 2020, Mr. Mallett served as Executive Vice President and Chief Operations Officer of Summit Midstream Partners, LP. In addition, from February to September 2019, he served as Summit’s Interim Chief...

Continue reading

Computer Modelling Group Announces Director Appointment

CALGARY, Alberta, Jan. 20, 2021 (GLOBE NEWSWIRE) — The Board of Directors of Computer Modelling Group Ltd. (“CMG” or the “Company”) (TSX: CMG) today announces that Mr. John Billowits has been appointed to the Board of Directors effective January 20, 2021.Mr. Billowits brings deep software domain experience to CMG and currently holds Director positions with Constellation Software Inc. (“Constellation”), an international provider of market-leading software and services to a number of industries in both the public and private sectors, of Togetherwork, a privately held vertical market software company and of Topicus.com, a European provider of vertical market software and vertical market platforms to clients in both the public and private sectors. Until 2020, he served as Chief Executive Officer of Vela Software, a subsidiary...

Continue reading

Piedmont Office Realty Trust Announces Tax Treatment of 2020 Dividends

Atlanta, Jan. 20, 2021 (GLOBE NEWSWIRE) — Piedmont Office Realty Trust (NYSE: PDM) (“Piedmont”), a real estate investment trust (REIT), announced today the tax treatment of its 2020 common stock dividends as described below.  Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of Piedmont dividends.*The $0.21 per share distribution paid on January 3, 2020 was taxable to stockholders in 2019.** The $0.21 per share distribution paid on January 4, 2021 will be taxable to stockholders in 2021.About Piedmont Office Realty TrustPiedmont Office Realty Trust, Inc. (NYSE: PDM) is an owner, manager, developer, redeveloper, and operator of high-quality, Class A office properties located primarily in select sub-markets within seven major Eastern U.S. office markets, with the majority of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.